Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moskowitz

Showing results (211-220 of 298) with videos related to

Pageof 30
Sort By:
Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidenceAnnetine C Gelijns, Alan J Moskowitz, Patrick T O'Gara, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 21, 2020
Risk for non-home discharge following surgery for ischemic mitral valve diseaseAnuradha Lala, Helena L Chang, Xiaoyu Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 8, 2011
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace?Louis P Perrault, Alan J Moskowitz, Irving L Kron, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Blood|December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphomaAlex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Stroke|July 17, 2010
The ARUBA trial: current status, future hopesJ P Mohr, Alan J Moskowitz, Christian Stapf, et al.
Circulation|January 15, 2013
Prospective, multicenter study of ventricular assist device infectionsRachel J Gordon, Alan D Weinberg, Francis D Pagani, et al.
Blood|April 7, 2021
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study resultsRanjana H Advani, Alison J Moskowitz, Nancy L Bartlett, et al.
Blood Advances|March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysisJulia Driessen, Fer de Wit, Alex F Herrera, et al.
Pageof 30

Showing results (211-220 of 298) with videos related to

Sort By:
Pageof 30
Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2020
Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidenceAnnetine C Gelijns, Alan J Moskowitz, Patrick T O'Gara, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 21, 2020
Risk for non-home discharge following surgery for ischemic mitral valve diseaseAnuradha Lala, Helena L Chang, Xiaoyu Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 8, 2011
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace?Louis P Perrault, Alan J Moskowitz, Irving L Kron, et al.
American Journal of Hematology|March 25, 2024
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationRobert Stuver, Agrima Mian, Samantha Brown, et al.
Blood|December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphomaAlex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Stroke|July 17, 2010
The ARUBA trial: current status, future hopesJ P Mohr, Alan J Moskowitz, Christian Stapf, et al.
Circulation|January 15, 2013
Prospective, multicenter study of ventricular assist device infectionsRachel J Gordon, Alan D Weinberg, Francis D Pagani, et al.
Blood|April 7, 2021
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study resultsRanjana H Advani, Alison J Moskowitz, Nancy L Bartlett, et al.
Blood Advances|March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysisJulia Driessen, Fer de Wit, Alex F Herrera, et al.
Pageof 30